392 related articles for article (PubMed ID: 38005401)
1. Joining Forces: The Combined Application of Therapeutic Viruses and Nanomaterials in Cancer Therapy.
Li H; Zhu Y; Wang X; Feng Y; Qian Y; Ma Q; Li X; Chen Y; Chen K
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005401
[TBL] [Abstract][Full Text] [Related]
2. Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses.
Zarezadeh Mehrabadi A; Roozbahani F; Ranjbar R; Farzanehpour M; Shahriary A; Dorostkar R; Esmaeili Gouvarchin Ghaleh H
World J Surg Oncol; 2022 Jan; 20(1):16. PubMed ID: 35027068
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
4. The role of viruses in cancer development versus cancer therapy: An oncological perspective.
Javid H; Sharbaf Mashhad A; Yazdani S; Akbari Oryani M; Akbari S; Rezagholinejad N; Tajaldini M; Karimi-Shahri M
Cancer Med; 2023 May; 12(10):11127-11148. PubMed ID: 36880311
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic virotherapy: Challenges and solutions.
Goradel NH; Baker AT; Arashkia A; Ebrahimi N; Ghorghanlu S; Negahdari B
Curr Probl Cancer; 2021 Feb; 45(1):100639. PubMed ID: 32828575
[TBL] [Abstract][Full Text] [Related]
6. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.
Wang X; Shen Y; Wan X; Hu X; Cai WQ; Wu Z; Xin Q; Liu X; Gui J; Xin HY; Xin HW
J Transl Med; 2023 Jul; 21(1):500. PubMed ID: 37491263
[TBL] [Abstract][Full Text] [Related]
7. Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer.
Kana SI; Essani K
Mol Diagn Ther; 2021 May; 25(3):301-313. PubMed ID: 33713031
[TBL] [Abstract][Full Text] [Related]
8. Kinase inhibitors with viral oncolysis: Unmasking pharmacoviral approaches for cancer therapy.
Gilchrist VH; Jémus-Gonzalez E; Said A; Alain T
Cytokine Growth Factor Rev; 2020 Dec; 56():83-93. PubMed ID: 32690442
[TBL] [Abstract][Full Text] [Related]
9. Development of oncolytic viruses for cancer therapy.
Abd-Aziz N; Poh CL
Transl Res; 2021 Nov; 237():98-123. PubMed ID: 33905949
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses.
Hadryś A; Sochanik A; McFadden G; Jazowiecka-Rakus J
Eur J Pharmacol; 2020 May; 874():172991. PubMed ID: 32044323
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia effects on oncolytic virotherapy in Cancer: Friend or Foe?
Sadri M; Najafi A; Rahimi A; Behranvand N; Hossein Kazemi M; Khorramdelazad H; Falak R
Int Immunopharmacol; 2023 Sep; 122():110470. PubMed ID: 37433246
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic viruses as a promising therapeutic strategy for hematological malignancies.
Yang C; Hua N; Xie S; Wu Y; Zhu L; Wang S; Tong X
Biomed Pharmacother; 2021 Jul; 139():111573. PubMed ID: 33894623
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic Viruses: The Best is Yet to Come.
Lemay CG; Keller BA; Edge RE; Abei M; Bell JC
Curr Cancer Drug Targets; 2018; 18(2):109-123. PubMed ID: 28176648
[TBL] [Abstract][Full Text] [Related]
15. Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?
Naik JD; Twelves CJ; Selby PJ; Vile RG; Chester JD
Clin Cancer Res; 2011 Jul; 17(13):4214-24. PubMed ID: 21576084
[TBL] [Abstract][Full Text] [Related]
16. Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.
Wennier ST; Liu J; McFadden G
Curr Pharm Biotechnol; 2012 Jul; 13(9):1817-33. PubMed ID: 21740354
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic Viruses on Drugs: Achieving Higher Therapeutic Efficacy.
Phan M; Watson MF; Alain T; Diallo JS
ACS Infect Dis; 2018 Oct; 4(10):1448-1467. PubMed ID: 30152676
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
Zhang Y; Liu Z
Curr Pharm Des; 2019; 25(40):4251-4263. PubMed ID: 31682207
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic viruses for cancer immunotherapy.
Hemminki O; Dos Santos JM; Hemminki A
J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
[TBL] [Abstract][Full Text] [Related]
20. Developing Oncolytic Viruses for the Treatment of Cervical Cancer.
Kalafati E; Drakopoulou E; Anagnou NP; Pappa KI
Cells; 2023 Jul; 12(14):. PubMed ID: 37508503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
